Skip to content

Radiographic Migration Analysis of the Insignia Hip Stem

Radiographic Migration Analysis of the Insignia Hip Stem

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06696313
Enrollment
25
Registered
2024-11-20
Start date
2025-01-15
Completion date
2027-12-31
Last updated
2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Implant, Hip Replacement in Osteoarthritis Patients, Migration of Implant

Keywords

Insignia, RSA, Total hip replacement

Brief summary

The purpose of this study is to assess the migration pattern of the Insignia hip stem using radiostereometric analysis (RSA for short) and computed tomography (CT). Only patients with degenerative joint disease requiring primary total hip replacement will be asked to participate. The other purpose is to assess if there are any differences between the gold-standard RSA-measured migration and CT-RSA-measured migration. The clinical outcomes will be measured using joint function and patient satisfaction questionnaires. Approximately thirty patients will be enrolled onto the study.

Detailed description

This is a single-centre, non-randomized, non-controlled trial of patients undergoing primary total hip arthroplasty using the Insignia hip stem. Patients will undergo RSA and CT-RSA imaging and analyses to identify migration of the femoral stem with respect to the adjuvant bone during the first 2 post-operative years. The primary outcome of this study is to determine if femoral stem stability is achieved between 6-12 month and 12-24 month post-operative intervals.

Interventions

DEVICEInsignia

* Insignia hip stem * Trident hemispherical shell * X3 polyethylene liner * Metal or ceramic head

Sponsors

Orthopaedic Innovation Centre
CollaboratorOTHER
Canadian Radiostereometric Analysis Network
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Symptomatic osteoarthritis of the hip indicating primary total hip arthroplasty - Aged 21 years or older * Patients willing and able to comply with follow-up requirements and self-evaluations * Ability to give informed consent

Exclusion criteria

* Active or prior infection * Medical condition precluding major surgery * Medical condition with less than 2 years life expectancy * Overhanging pannus (direct anterior approach) * Prior surgery of the hip involving implantation of hardware (i.e., hemiarthroplasty, internal fixation, pelvic reconstruction near the acetabulum requiring removal) * Skin condition on the area of incision * Multi-level lumbar spine fusion * Ankylosing spondylolithesis * Shortening osteotomy through the femur

Design outcomes

Primary

MeasureTime frameDescription
MigrationUp to 2 years post-operativeQuantify migration of the Insignia stem using RSA and CT-RSA

Secondary

MeasureTime frameDescription
Early migrationUp to 2 years post-operativeQuantify early migration of the Trident acetabular cup using RSA
ValidationUp to 2 years post-operativeComparison of RSA and CT-RSA using the standard deviation of the mean component migration calculated from examinations.
Changes in Oxford-12 Hip Score from baseline(pre-op) to 6-month, 1-year and 2-yearUp to 2 years post-operativeThe Oxford Hip Score (OHS) is a patient self-administered 12-item questionnaire with each question having a Likaert-like response option. Each item is scored from 0 to 4, and the items are summated, with lower total scores indicating poorer performance. The OHS measures pain and general activities of daily living
Changes in EQ-5D-5L from baseline(pre-op) to 6-month, 1-year and 2-yearUp to 2 years post-operativeThe EuroQol 5D 5L questionnaire is a standardized instrument for use as a measure of health outcome that is designed for completion by the subject.
Changes in Patient Satisfaction (VAS) from baseline(pre-op) to 6-month, 1-year and 2-yearUp to 2 years post-operativeEvaluate and compare the change from preoperative to 2 years in patient reported satisfaction as measured using the visual analogue scale (VAS) from 0 (Unsatified) - 100 (Completely Satisfied).

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026